Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
2(100.0%)
2Total
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05339425Completed

Chinese Osteoporotic Fracture Registration Network Platform

Role: collaborator

NCT06473493Phase 2Not Yet Recruiting

The Safety and Efficacy of Alverine in the Treatment of Cirrhotic Portal Hypertension

Role: collaborator

NCT06470386Phase 2Not Yet Recruiting

The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver Cirrhosis

Role: collaborator

All 3 trials loaded